{"id":10457,"date":"2006-11-16T07:48:52","date_gmt":"2006-11-16T06:48:52","guid":{"rendered":"http:\/\/www.fedaiisf.it\/farmaci-prezzi-piu-bassi-del-40\/"},"modified":"2006-11-16T07:48:52","modified_gmt":"2006-11-16T06:48:52","slug":"farmaci-prezzi-piu-bassi-del-40","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/farmaci-prezzi-piu-bassi-del-40\/","title":{"rendered":"Drugs, prices lower than 40%"},"content":{"rendered":"<p><span class=\"Style_3\"> <\/p>\n<p align=\"justify\"><span class=\"Style_6\">\u201cThe Finance Law, as it stands, is not working.<\/span> Also for 2007 it confirms the cuts already implemented this year, bringing drug prices below the European average, with peaks of <span class=\"Style_6\">40%<\/span> in less. Companies like this are not able to make investment plans\u201d. This is the analysis of <span class=\"Style_6\">Enrica Giorgetti,<\/span> general manager of Farmindustria, who spoke yesterday at a meeting on the future of multinational drug companies based in Italy, promoted in Rome by the Italian American Pharmaceutical Group and the European Group of Farmindustria.<\/p>\n<div align=\"justify\">The situation for pharmaceuticals in our country &quot;is disappointing - he explains - above all because we had proposed a development pact to the government, in which companies put 2 billion euros in investments on the plate over the next three years, with a further commitment to research and an increase in 35% resources&quot;. But the executive&#039;s response was \u201ca further cut in drug prices. The scenario is very worrying - he underlines - and the risk that companies decide to leave is real. <span class=\"Style_3\">Italy needs to attract new investments and maintain existing ones, which is why the Government must take up the sector&#039;s cry of alarm\u201d.&nbsp;<\/span> From Doctornews 11-13-06<\/div>\n<div>&nbsp;<\/div>\n<p> <\/span><\/p>","protected":false},"excerpt":{"rendered":"<p>&#8220;La Finanziaria, cos&#236; com&#8217;&#232;, non va. Conferma anche per il 2007 i tagli gi&#224; attuati quest&#8217;anno, portando i prezzi dei farmaci al di sotto della media europea, con punte del 40% in meno. Le aziende cos&#236; non sono in grado di fare programmi di investimento&#8221;. Questa l&#8217;analisi di Enrica Giorgetti, direttore generale di Farmindustria, intervenuta &hellip;<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-10457","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/10457","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=10457"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/10457\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=10457"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=10457"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=10457"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}